首页> 外文期刊>Morbidity and Mortality Weekly Report: CDC Surveillance Summaries >Expansion of HIV Preexposure Prophylaxis to 35 PEPFAR-Supported Early Program Adopters, October 2016–September 2018
【24h】

Expansion of HIV Preexposure Prophylaxis to 35 PEPFAR-Supported Early Program Adopters, October 2016–September 2018

机译:扩增HIV预防预防35百分点支持的早期计划采用者,2016年10月 - 2018年9月

获取原文
获取外文期刊封面目录资料

摘要

The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the largest bilateral funder of human immunodeficiency virus (HIV) prevention and control programs worldwide, currently supports implementation of preexposure prophylaxis (PrEP) to reduce HIV incidence among persons at substantial risk for infection, including female sex workers, men who have sex with men (MSM), and transgender women (hereafter referred to as key populations). Recent estimates suggest that 54% of all global new HIV infections in 2018 occurred among key populations and their sexual partners ( 1 ). In 2016, PEPFAR began tracking initiation of PrEP by key populations and other groups at high risk ( 2 ). The implementation and scale-up of PrEP programs across 35 PEPFAR-supported country or regional programs * was assessed by determining the number of programs reporting any new PrEP clients during each quarter from October 2016 to September 2018. As of September 2018, only 15 (43%) PEPFAR-supported country or regional programs had implemented PrEP programs; however, client volume increased by 3,351% over the assessment period in 15 country or regional programs. Scale-up of PrEP among general population clients (5,255%) was nearly three times that of key population clients (1,880%). Among key populations, the largest increase (3,518%) occurred among MSM. Factors that helped drive the success of these PrEP early adopter programs included initiation of national, regional, and multilateral stakeholder meetings; engagement of ministries of health and community advocates; revision of HIV treatment guidelines to include PrEP; training for HIV service providers; and establishment of drug procurement policies. These best practices can help facilitate PrEP implementation, particularly among key populations, in other country or regional programs to reduce global incidence of HIV infection.
机译:美国总统艾滋病救济(百氟铝)的应急计划是全世界人民免疫缺陷病毒(艾滋病毒)预防和控制方案的最大双侧呼吸器,目前支持预防预防(PREP),以减少感染风险的人群中的艾滋病毒发病率,包括女性性工作者,与男性(MSM)和跨性别妇女发生性关系的男性(以下简称为关键人群)。最近的估计表明,2018年全球全球新艾滋病毒感染的54%发生在关键人群及其性伴侣(1)之间发生。 2016年,佩福尔开始在高风险(2)处按关键人群和其他群体跟踪准备的启动。通过确定2016年10月至2018年9月在每季度报告任何新准备客户的方案数目,评估了35个百分点支持的国家或区域计划*的准备计划*的实施和扩大。截至2018年9月,截至2018年9月,仅15份( 43%的人支持的国家或区域方案实施了准备计划;但是,在15个国家或区域方案的评估期内,客户体积增加了3,351%。一般人口客户(5,255%)的准备扩大近三倍,关键人口客户(1,880%)。在关键种群中,MSM中最大的增加(3,518%)发生。有助于推动这些准备早期采用计划成功的因素包括启动国家,区域和多边利益攸关方会议;卫生和社区倡导者部门的参与;修订艾滋病毒治疗指南,包括准备;艾滋病毒服务提供商培训;并建立毒品采购政策。这些最佳实践可以帮助促进准备实施,特别是在其他国家或区域方案中的主要人群中,以减少全球艾滋病毒感染发病率。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号